LINC02634

Across TCGA pan-cancer cohorts, LINC02634 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC02634 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02634 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02634 expression acts as an unfavorable survival marker, although some lineages such as COAD and SKCM show a favorable association.

BLCA, UVM, and COAD are the cancer types where LINC02634 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.221	0.519	.001	21	view →
UVM	DFS	Tertile	III,IV	0.107	0.677	.004	18	view →
COAD	DFS	Tertile	III,IV	0.858	0.278	.004	15	view →
STAD	OS	Median	IV	0.156	0.511	.001	12	view →
LAML	DFS	Tertile	All	0.292	0.530	.010	12	view →
PAAD	DFS	Tertile	II,III,IV	0.314	0.521	.023	10	view →
SKCM	OS	Tertile	All	0.436	0.289	.027	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →
UCEC	DFS	Tertile	All	0.856	0.908	.045	6	view →
ACC	DFS	Quartile	IV	0.551	0.107	.017	6	view →
GBM	DFS	Median	All	0.355	0.208	.048	3	view →
KIRC	DFS	Tertile	II,III,IV	0.786	0.646	.023	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC02634–BLCA (DFS)

Open the BLCA breakdown →